Xiaoyan Shi Selected Research

Oxygen (Dioxygen)

1/2023

Clinical effect of high-flow nasal cannula oxygen therapy combined with naloxone on severe respiratory failure in older adult patients: a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoyan Shi Research Topics

Disease

37	Neoplasms (Cancer) 01/2024 - 04/2004
10	Neoplasm Metastasis (Metastasis) 12/2022 - 07/2004
10	Breast Neoplasms (Breast Cancer) 11/2022 - 07/2004
6	Atherosclerosis 02/2024 - 01/2021
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 07/2007
5	Hepatocellular Carcinoma (Hepatoma) 08/2022 - 09/2011
5	Carcinoma (Carcinomatosis) 01/2014 - 07/2004
4	Inflammation (Inflammations) 01/2024 - 01/2020
4	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2013
3	Insulin Resistance 01/2021 - 01/2019
3	Carcinogenesis 12/2018 - 01/2009
3	Lymphoma (Lymphomas) 05/2017 - 10/2010
2	Osteoporosis 02/2024 - 01/2022
2	Infections 01/2024 - 08/2006
2	Poisoning 01/2023 - 10/2021
2	Fatigue 12/2022 - 10/2002
2	Shock 10/2022 - 08/2006
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 06/2013
2	Spontaneous Abortion (Miscarriage) 10/2020 - 10/2013
2	Hypertension (High Blood Pressure) 06/2020 - 08/2018
2	Sarcoma (Soft Tissue Sarcoma) 10/2019 - 08/2019
2	Liver Neoplasms (Liver Cancer) 01/2019 - 05/2017
2	Colonic Neoplasms (Colon Cancer) 12/2018 - 11/2018
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2013 - 09/2009
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2012 - 03/2011
1	Human Influenza (Influenza) 03/2024
1	Anemia 01/2024
1	Epilepsy (Aura) 01/2024
1	Seizures (Absence Seizure) 01/2024
1	Hyperglycemia 01/2023
1	Respiratory Insufficiency (Respiratory Failure) 01/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Insulinoma 01/2023
1	Pancreatitis 01/2023

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2004
7	paeonolIBA 02/2024 - 10/2020
6	MicroRNAs (MicroRNA)IBA 02/2024 - 01/2018
5	CystathionineIBA 01/2021 - 05/2017
4	Insulin (Novolin)FDA Link 01/2023 - 06/2020
4	Messenger RNA (mRNA)IBA 01/2023 - 08/2004
4	Interleukin-12 (IL 12)IBA 01/2009 - 04/2004
3	IronIBA 01/2024 - 11/2022
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2019
3	LyasesIBA 01/2021 - 09/2017
3	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2019
3	Cisplatin (Platino)FDA LinkGeneric 10/2019 - 04/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2018 - 11/2009
3	DNA (Deoxyribonucleic Acid)IBA 02/2018 - 08/2002
2	Apolipoproteins E (ApoE)IBA 02/2024 - 01/2022
2	Sirtuin 1IBA 01/2024 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
2	3' Untranslated Regions (3' UTR)IBA 12/2022 - 01/2009
2	CurcuminIBA 08/2022 - 06/2013
2	Immunoglobulin G (IgG)IBA 01/2022 - 08/2002
2	LipopolysaccharidesIBA 01/2022 - 08/2006
2	Caspase 3 (Caspase-3)IBA 01/2022 - 05/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 10/2002
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 06/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2017
2	PaxillinIBA 01/2021 - 08/2019
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 06/2020
2	Uric Acid (Urate)IBA 06/2020 - 01/2020
2	Vitamin E FDA LinkGeneric 01/2020 - 11/2009
2	Peptides (Polypeptides)IBA 01/2019 - 01/2018
2	Small Interfering RNA (siRNA)IBA 12/2018 - 05/2017
2	Histones (Histone)IBA 11/2018 - 08/2002
2	Pyruvate KinaseIBA 04/2017 - 02/2017
2	Tumor Biomarkers (Tumor Markers)IBA 04/2017 - 02/2017
2	IsoenzymesIBA 04/2017 - 02/2017
2	Rituximab (Mabthera)FDA Link 07/2014 - 07/2013
2	Immunoconjugates (Immunoconjugate)IBA 07/2013 - 09/2009
2	Monoclonal AntibodiesIBA 01/2012 - 03/2011
2	dacetuzumabIBA 03/2011 - 10/2010
2	Vascular Endothelial Growth Factor CIBA 03/2008 - 07/2007
2	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 03/2008 - 07/2007
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2008 - 07/2007
2	AutoantibodiesIBA 09/2007 - 08/2002
2	Interferon-gamma (Interferon, gamma)IBA 08/2006 - 08/2004
1	VaccinesIBA 03/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2024
1	Hemoglobins (Hemoglobin)IBA 01/2024
1	Lacosamide FDA Link 01/2024
1	AcidsIBA 10/2023
1	Drinking WaterIBA 10/2023
1	ApoferritinsIBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	5-iodotubercidinIBA 01/2023
1	Naloxone (Narcan)FDA LinkGeneric 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Ferritins (Ferritin)IBA 01/2023
1	purineIBA 01/2023
1	Sincalide FDA Link 01/2023
1	Radioisotopes (Radionuclides)IBA 01/2023
1	toripalimabIBA 01/2023

Therapy/Procedure

7	Therapeutics 01/2024 - 03/2011
6	Drug Therapy (Chemotherapy) 01/2023 - 01/2005
1	Contraindications 03/2024
1	Aftercare (After-Treatment) 01/2024
1	Cannula 01/2023